View Older Stories View More Recent Stories
-
RBC Capital Starts Ultragenyx Pharma (RARE) at Outperform 'Given Base Business Offers Downside Protection & OI Material Upside Potential'
-
Phoenix Group (PHNX:LN) (PHXXF) PT Raised to GBP6.15 at RBC Capital
-
Pagegroup Plc. (PAGE:LN) (MPGPY) PT Lowered to GBP5.40 at RBC Capital
-
Hays Plc. (HAS:LN) (HAYPF) PT Lowered to GBP1.30 at RBC Capital
-
ABB LTD (ABBN:SW) (ABB) PT Raised to CHF45 at RBC Capital
-
Synovus Financial (SNV) PT Lowered to $41 at RBC Capital
-
Marsh & McLennan (MMC) PT Raised to $210 at RBC Capital
-
Liberty Oilfield Services (LBRT) PT Raised to $27 at RBC Capital
-
KeyCorp (KEY) PT Raised to $16 at RBC Capital
-
Elevance (ELV) PT Raised to $575 at RBC Capital
-
D.R. Horton (DHI) PT Lowered to $141 at RBC Capital
-
Comerica (CMA) PT Raised to $62 at RBC Capital
-
RBC Capital Starts Inspire Medical Systems (INSP) at Outperform
-
China set to keep lending benchmark LPRs unchanged in April
-
Utz Brands Announces Continued Acceleration of Supply Chain Transformation Strategy and Completes Term Loan Repricing
-
Korro Bio (KRRO) Announces $70M Placement
-
Korro Announces $70 Million Private Placement
-
Spire Healthcare (SPI:LN) (SRRHF) PT Raised to GBP3.10 at RBC Capital
-
Ashtead Technology Holdings plc (AT:LN) PT Raised to GBP7.80 at RBC Capital
-
MediaCo (MDIA) Acquires Estrella Media’s Content and Digital Operations
-
MediaCo Acquires Estrella Media’s Content and Digital Operations
-
Travelers (TRV) PT Lowered to $225 at RBC Capital
-
CSX (CSX) PT Lowered to $36 at RBC Capital
-
Abbott Labs (ABT) PT Lowered to $125 at RBC Capital
-
Intra-Cellular Therapies (ITCI) Prices Public Offering of Common Stock
-
Intra-Cellular Therapies Prices Public Offering of Common Stock
-
Royal Bank of Canada announces NVCC AT1 Limited Recourse Capital Notes issue
-
Clearwater Analytics to Participate in Upcoming Investor Conferences in Second Quarter 2024
-
RBC Capital Reiterates Outperform Rating on Bank of America (BAC)
-
RBC Capital Cautious on ProLogis (PLD): 'customers remain focused on controlling costs'
-
RBC Capital Issues Negative Sentiment on Sage Therapeutics (SAGE), 'we are not altogether surprised by the stock move'
-
Ashtead Group Plc (AHT:LN) (ASHTY) PT Raised to GBP53 at RBC Capital
-
RBC Capital Upgrades Pennon Group Plc. (PNN:LN) (PEGRF) to Outperform
-
Abbott's device sales drive profit beat, but shares fall as forecast disappoints
-
UnitedHealth Group (UNH) PT Lowered to $555 at RBC Capital
-
Nuvation Bio Inc (NUVB) PT Raised to $5 at RBC Capital
-
Johnson & Johnson (JNJ) PT Lowered to $175 at RBC Capital
-
APi Group Corporation (APG) Prices 11M Share Offering at $37.50/sh
-
APi Group Announces Pricing of Public Offering of Common Stock
-
Analysis-Indonesia's plunging rupiah twists the policy plot
-
Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Intra-Cellular Therapies (ITCI) Announces Proposed $500M Share Offering
-
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
-
RBC Capital Markets launches RBC Clear™, a Cash Management solution that will focus on Fortune 1000 corporations in the United States
-
RBC Capital Upgrades Admiral Group Plc. (ADM:LN) (AMIGY) to Outperform
-
Ducommun (DCO) Rejects Unsolicited, Non-Binding Indication of Interest From Albion River
-
Ducommun Incorporated Rejects Unsolicited, Non-Binding Indication of Interest From Albion River
-
Goldman Sachs (GS) PT Raised to $405 at RBC Capital
-
Boeing (BA) PT Lowered to $215 at RBC Capital
-
China's cycle of dollar hoarding and weakening yuan gets vicious

